Soluble beta-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells.

作者: V Vetvicka , B P Thornton , G D Ross

DOI: 10.1172/JCI118777

关键词:

摘要: When phagocyte CR3 binds to iC3b on bacteria or yeast, phagocytosis and degranulation are triggered because of simultaneous recognition via a CD11b I-domain binding site specific microbial polysaccharides lectin located COOH-terminal the I-domain. By contrast, when natural killer (NK) cell adheres erythrocytes tumor cells that lack CR3-binding membrane polysaccharides, neither lysis nor cytotoxicity stimulated. This investigation showed soluble CR3-specific such as beta-glucan induced primed state could trigger killing iC3b-target were otherwise resistant cytotoxicity. Anti-CR3 added before sugars prevented priming, whereas anti-CR3 after blocked attachment iC3b-targets. Polysaccharide priming required tyrosine kinase(s) magnesium-dependent conformational change exposed CBRM1/5 activation epitope. Unlike LPS cytokines, did not up-regulate neutrophil expression expose mAb 24 reporter epitope representing high affinity ICAM-1-binding state. The current data apparently explain mechanism tumoricidal beta-glucans used for immunotherapy. These function through NK CR3, receptor neoplastic tissues frequently targeted with sparing normal iC3b.

参考文章(86)
R Hirayama, K Enomoto, J Yata, R Noguchi, J Matsumura, M Amino, Y Asato, O Abe, [Studies on the effect of lentinan on human immune system. II. In vivo effect on NK activity, MLR induced killer activity and PHA induced blastic response of lymphocytes in cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy. ,vol. 10, pp. 2000- 2006 ,(1983)
T Taguchi, Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey. Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc. ,vol. 1, pp. 333- 349 ,(1987)
F Oowada, T Yamada, K Nakagomi, K Tari, I Satake, Y Higashi, T Negishi, K Ozawa, K Yoshida, H Saito, Effect of lentinan for advanced prostate carcinoma Hinyokika kiyo. Acta urologica Japonica. ,vol. 40, pp. 119- 123 ,(1994)
Tetsuo Taguchi, Hisashi Furue, Tadashi Kimura, Tatsuhei Kondo, Takao Hattori, Nobuya Ogawa, Clinical Efficacy of Lentinan on Neoplastic Diseases Advances in Experimental Medicine and Biology. ,vol. 166, pp. 181- 187 ,(1983) , 10.1007/978-1-4757-1410-4_15
Helen Coley Nauts, Walker E. Swift, Bradley L. Coley, The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research. Cancer Research. ,vol. 6, pp. 205- 216 ,(1946)
PH Naccache, N Jean, NW Liao, JM Bator, SR McColl, P Kubes, Regulation of Stimulated Integrin Surface Expression in Human Neutrophils by Tyrosine Phosphorylation Blood. ,vol. 84, pp. 616- 624 ,(1994) , 10.1182/BLOOD.V84.2.616.BLOODJOURNAL842616
R. M. COOK, Immune modulation agents and their mechanisms Biochemical Society Transactions. ,vol. 13, pp. 1257- 1257 ,(1985) , 10.1042/BST0131257A
Y Y Maeda, G Chihara, H Yonekawa, M Sakaizumi, K Moriwaki, Genetical control on lentinan-induced acute phase responses and vascular responses. Folia Histochemica Et Cytobiologica. ,vol. 30, pp. 207- 209 ,(1992)